NCT04312412 Outcome of the Treatment of Flexor Tendon Injuries
| NCT ID | NCT04312412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Zurich |
| Condition | Finger Injuries |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2014-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2014-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In order to gather enough data for meaningful statistics, a multicenter register of all flexor tendon repairs was established with surgical, clinical and rehabilitation patient data. The controlled active motion (CAM) protocol was administered in all patients after surgery. The purpose was to (i) measure surgery and therapy outcomes in the three centers and (ii) evaluate potential influencing factors on outcomes.
Eligibility Criteria
Inclusion Criteria: * Injury between 2014 and 2025 * Flexor tendon injury of the fingers or thumb in zones 1-3 Exclusion Criteria: * No given consent * Concomitant injuries as fractures, large soft tissue injuries, replantation * Bony avulsion fracture of flexor tendon (Jersey finger) * Basic disease as rheumatoid diseases * Primary and secondary tendon reconstruction and tendon transfer
Contact & Investigator
Maurizio Calcagni, PD Dr. med.
PRINCIPAL INVESTIGATOR
University of Zurich
Frequently Asked Questions
Who can join the NCT04312412 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Finger Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04312412 currently recruiting?
Yes, NCT04312412 is actively recruiting participants. Contact the research team at vera.beckmann-fries@usz.ch for enrollment information.
Where is the NCT04312412 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT04312412 clinical trial?
NCT04312412 is sponsored by University of Zurich. The principal investigator is Maurizio Calcagni, PD Dr. med. at University of Zurich. The trial plans to enroll 500 participants.